Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA Approves Egrifta to Treat Lipodystrophy in HIV Patients

November 27, 2010Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

lipodystrophy

Post navigation

← Recall of Tylenol Cold Liquid Products FDA approves new treatment option for late-stage breast cancer →
Proudly powered by WordPress